JOSEPH H. PORTER
Presentations
INVITED PRESENTATIONS
Invited Presentation in the Department of Psychology at Northern Michigan University in Marquette, Michigan KETAMINE: Anesthetic, Drug of Abuse, or Antidepressant? March 29, 2013
Invited presentation for Symposium on the Psychopharmacology of Antipsychotics at the American Psychological Association meeting in Orlando, Florida. What Can Drug Discrimination Tell Us About Antipsychotic Drugs? August 4, 2012
Invited Presentation in the Department of Psychology at Duke University in Durham, North Carolina, What can drug discrimination tell us about antipsychotic drugs? May 14, 2012
Invited Presentation at Northern Michigan University in Marquette, Michigan – Department of Psychology in Marquette, MI on May 12, 2009 – Title: “What Can Mice Tell Us About Treating Schizophrenia?”
Invited Presentation at Oregon Health & Science University – Department of Behavioral Neuroscience at Oregon Health & Science University in Portland, OR on September 10, 2008 – Title: “Of mice & rats: The discriminative stimulus properties of the atypical antipsychotic drug clozapine”
Invited Presentation at University of Richmond – Department of Psychology at University of Richmond in Richmond, VA on March 26, 2008 – Title: “SCHIZOPHRENIA: Symptoms, Etiology, Treatment”
Invited Presentation at Grand Rounds – Department of Psychiatry at Vanderbilt University in Nashville, TN on November 18, 2004 – Title: “Behavioral Assays for Screening Novel Antipsychotic Drugs”
Invited Presentation at Roche Laboratories – Palo Alto, CA on October 24, 2004 – Title: “Preclinical Behavioral Models for Screening Drugs: Drug Discrimination and Cognitive Tasks”
Invited Presentationat the Zyprexa Investigator-Initiated Trials Program Meeting sponsored by Eli Lilly and Company in Dallas, TX on February 2, 2001 – Title: “An in vivo behavioral test of the anticholinergic effects of olanzapine and clozapine in rats”
RECENT Conference Presentations, Oral Presentations and Published Abstracts
Porter JH, Donahue TJ, Hillhouse TM, Webster KA, Young R, De Oliveira EO (2015) The Unique Discriminative Stimulus Properties of the Atypical Antipsychotic Amisulpride in C57BL/6 Mice. Oral presentation at the Behavioral Pharmacology Society, 58th annual meeting in Boston, MA on March 28, 2015
Moisa LT, Donahue TJ, Porter JH (2014) Compound 4560 RP and the Birth of Psychopharmacology. Poster presentation at Society for Neuroscience, 43rd Annual Meeting, Washington. D.C. November 12-19
Donahue TJ, Webster KA, Hillhouse TM, King JC, Kennedy LM, De Oliveira EO, Porter JH (2014) Characterization of the discriminative stimulus properties of the racemic form of the atypical antipsychotic drug amisulpride in C57BL/6 mice. Poster presentation at Society for Neuroscience, 43rd Annual Meeting, Washington. D.C. November 12-19
Stewart JK, Webster KA, Fischer-Stenger K, Geng Y, Gonye EC, Windle JJ, Porter JH (2014) Age and sex differences in operant learning and corticosterone in vesicular monoamine transporter 1 depleted mice (VMAT1-/-). Poster presentation at Society for Neuroscience, 43rd Annual Meeting, Washington. D.C. November 12-19
Webster KA, Beardsley PM, Windle JJ, Stewart JK, Porter JH (2014) Exploring behavioral outcomes of vesicular monoamine transporter 1 depletion (VMAT1-/-) in young and aged mice. Poster presentation at Society for Neuroscience, 43rd Annual Meeting, Washington. D.C. November 12-19
Merritt CM, Webster KA, Windle JJ, Stewart JK, Porter JH (2014) Examining the motoric effects of vesicular monoamine transporter 1 depletion (VMAT1-/-) in young and aged mice. Poster presentation at Society for Neuroscience, 43rd Annual Meeting, Washington. D.C. November 12-19
Friar MA, Hillhouse TM, Webster KA, Porter JH (2014) Antidepressant-like effects of ketamine in the Differential Reinforcement-of-Low-Rate (DRL) 72 sec operant procedure in mice. Poster presentation at Society for Neuroscience, 43rd Annual Meeting, Washington. D.C. November 12-19
Porter JH, Merritt CM, Hillhouse TM (2014) Differential serotonergic mechanisms of the noncompetitive NMDA receptor antagonists ketamine, memantine, MK-801 in the Differential Reinforcement-of-Low-Rate (DRL) 72 s procedure in rats. Poster presentation at Society for Neuroscience, 43rd Annual Meeting, Washington. D.C. November 12-19
Joseph BL, Popal HS, Hillhouse TM, Porter JH (2014) Discriminative stimulus properties of the noncompetitive N-Methyl-D-aspartate (NMDA) receptor antagonist ketamine in rats. Poster presentation at Society for Neuroscience, 43rd Annual Meeting, Washington. D.C. November 12-19
Donahue TJ, Webster KA, Hillhouse TM, De Oliveira EO, Friar MA, Porter JH (2013) Discriminative stimulus properties of the typical antipsychotic haloperidol in C57BL/6 mice. Poster presentation at Society for Neuroscience, 43rd Annual Meeting, San Diego, CA, November 9-13
Hillhouse TM, Porter JH, Negus SS (2013) Effects of acute and chronic ketamine administration on intracranial self-stimulation (ICSS) in rats. Poster presentation at Society for Neuroscience, 43rd Annual Meeting, San Diego, CA, November 9-13
Joseph BL, Hillhouse TM, Steele FF, Porter JH (2013) Dissociable effects of the noncompetitive NMDA antagonists ketamine, phencyclidine (PCP), MK-801, and other glutamatergic ligands in the differential-reinforcement-of-low-rate (DRL) 72 sec task. Poster presentation at Society for Neuroscience, 43rd Annual Meeting, San Diego, CA, Nov 9-13
Mooney-Leber SM, Berquist, II MD, Pehrson AL, Porter NP, Porter JH, Prus A (2013) Effects of SSRI and SNRI antidepressant drugs on schedule-induced polydipsia in rats: Evaluation of α2 adrenoceptor antagonism with yohimbine. Poster presentation at Society for Neuroscience, 43rd Annual Meeting, San Diego, CA, November 9-13
Porter JH, Hillhouse TM (2013) The noncompetitive NMDA antagonist ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a differential-reinforcement-of-low-rate (DRL) 72 second operant schedule. Poster presentation at Society for Neuroscience, 43rd Annual Meeting, San Diego, CA, November 9-13
Webster KA, Hillhouse TM, Joseph BL, Donahue TJ, Fisher-Stenger K, Windle JJ, Stewart JK, Porter JH (2013) Vesicular monoamine transporter1 (VMAT1) depletion in mice produces behavioral deficits: Potential model for psychiatric disorders. Poster presentation at Society for Neuroscience, 43rd Annual Meeting, San Diego, CA, Nov 9-13
Hillhouse TM, Joseph BL, Steele FF, Negus SS, Porter JH (2013) Is ketamine an anesthetic, drug of abuse, or antidepressant? Poster presentation at European Behavioral Pharmacology Society, La Rochelle, France, September 6-9
Webster KA, Hillhouse TM, Joseph BL, Friar MA, Beardsley PM, Windle JJ, Stewart JK, Porter JH (2013) Effects of d-amphetamine in vesicular monoamine transporter (VMAT)1 knockout mice suggest a schizophrenic phenotype in conditioned and unconditioned behavior. Poster presentation at European Behavioral Pharmacology Society, La Rochelle, France, Sept 6-9
Donahue TJ, Webster KA, Hillhouse TM, De Oliveira EO, Friar MA, Porter JH (2013) A comparison of the discriminative stimulus properties of the atypical antipsychotic amisulpride and the typical antipsychotic haloperidol in C57BL/6 mice. Poster presentation at European Behavioral Pharmacology Society, La Rochelle, France, Sept 6-9
Porter J.H., Hillhouse T.M. (2013) The noncompetitive NMDA antagonist ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a DRL operant schedule. Oral presentation at the Meeting of the Behavioral Pharmacology Society in Boston, MA, April 20, 2013
Porter J.H., Hillhouse T.T. (2012) The noncompetitive NMDA antagonist ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a DRL operant schedule. Oral presentation at the Meeting of the Behavioral Pharmacology Society in Boston, MA, April 20, 2013
Hillhouse T.M., Porter J.H. (2012) Antidepressant-like effects of ketamine in rats responding on a differential-reinforcement-of-low-rate (DRL) operant schedule. Poster presentation at Society for Neuroscience, 42nd Annual Meeting, New Orleans, LA, October 13-17
Donahue T.J., Webster K.A., Hillhouse T.M., De Oliveira E.O., Porter J.H. (2012) Discriminative stimulus properties of the atypical antipsychotic amisulpride in C57BL/6 mice. Poster presentation at Society for Neuroscience, 42nd Annual Meeting, New Orleans, LA, October 13-17
Porter J.H., Webster K.A., Hillhouse T.M., Donahue T.J., Windle J.J., Stewart J.K. (2012) Behavioral deficits in vesicular monoamine transporter 1 (VMAT1) knockout mice. Poster presentation at Society for Neuroscience, 42nd Annual Meeting, New Orleans, LA, October 13-17
Webster K.A., Porter J.H. (2012) Establishing the atypical antipsychotic drug clozapine as a discriminative stimulus in male and female B6129/F1 hybrid mice. Poster presentation at Society for Neuroscience, 42nd Annual Meeting, New Orleans, LA, October 13-17
Webster K.A., Donahue T.J., Almond L.A., Stewart J.K., Porter J.H. (2011). Behavioral phenotyping of male and female B6129/F1 hybrid mice in an operant autoshaping task and open field activity. Program No. 608.18. 2011 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2011. Online.
Donahue T.J., Webster K.A., Wood E., Porter J.H. (2011). Acquisition of level press response versus nose poke response in an operant autoshaping task in C57BL/6 mice. Program No. 608.17. 2011 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2011. Online.
Porter J.H., Webster K.A., Philibin S.D., Walentiny D.M., Vunck S.A. (2011). Clozapine’s discriminative stimulus properties are mediated by different receptor mechanisms in three inbred mouse strains Program No. 567.23. 2011 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2011. Online.
Webster K.A., Wood E., Donahue T.J., Stewart J.K., Porter J.H. (2011). Comparison of B6129F1 Hybrid Mouse Strain with Parent Strains in Locomotor Activity and Cognitive Behavior. Poster presented at the meeting of the European Behavioural Pharmacology Society in Amsterdam, Netherlands, August, 2011.
Porter J.H., Webster K.A., Philibin S.D., Walentiny D.M., Vunck S.A. (2011). Phenotype Differences in Clozapine’s Discriminative Stimulus in C57BL/6, DBA/2, and 129S2 Inbred Mouse Strains. Poster presented at the meeting of the European Behavioural Pharmacology Society in Amsterdam, Netherlands, August, 2011.
Porter, J.H. (2011) Assessment of drug discrimination as a preclinical assay for development of antipsychotic drugs. New York Academy of Sciences Conference: Advancing Drug Discovery for Schizophrenia in New York, NY, March 9 - 11, 2011. Online access to my poster and abstract is at http://posters.f1000.com/P1116
Presentation at the Southeastern Psychological Association (SEPA) in Jacksonville, FL, March 2-5, 2011 - Wood, E., Martorell, E., King, A., Porter J. (2010) “A Behavioral Comparison of Four Inbred Strains of Mice”
Webster, K.A., Almond, L.M., Porter, J.H. (2010) Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in 129S2/SvHsd mice. Program No. 767.25. 2010 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2010. Online. (ABSTRACT of Poster presented at The Society for Neuroscience annual meeting in San Diego, CA)
Wiebelhaus, J.M., Webster, K.A., Renzulli, W.D., Meltzer, H.Y., Porter, J.H. (2010) N-desmethylolanzapine, but not haloperidol, induces cross-tolerance to the atypical antipsychotic clozapine’s discriminative stimulus in C57BL/6 mice. Program No. 767.26. 2010 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2010. Online. (ABSTRACT of Poster presented at The Society for Neuroscience annual meeting in San Diego, CA)
Vunck, S.A., Almond, L.M., Wise, L.E., Porter, J.H. (2010) The role of serotonin (5-HT) 2A antagonism in the discriminative stimulus properties of the atypical antipsychotic clozapine in rats and mice. Program No. 767.28. 2010 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2010. Online. (ABSTRACT of Poster presented at The Society for Neuroscience annual meeting in San Diego, CA)
Webster, K., Brimmer, G., Vunck, S.A., Wiebelhaus, J.M., Porter, J.H. (2009) The discriminative stimulus properties of the atypical antipsychotic drug clozapine in 129S2 mice. Program No. 840.11. 2009 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2009. Online. (ABSTRACT of Poster presented at The Society for Neuroscience annual meeting in Chicago, IL)
Wiebelhaus, J.M., Renzulli, W.D., Vunck, S.A., Meltzer, H.Y., Porter, J.H. (2009) The atypical antipsychotic clozapine substitutes for the discriminative stimulus associated with its major metabolite N-desmethylclozapine in C57BL/6 mice. Program No. 840.2. 2009 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2009. Online. (ABSTRACT of Poster presented at The Society for Neuroscience annual meeting in Chicago, IL)
Wiebelhaus, J.M., Meltzer, H.Y., Porter, J.H. (2009) N-desmethylclozapine induces cross-tolerance to the discriminative stimulus associated with the atypical antipsychotic clozapine in C57BL/6 mice. Program No. 840.9. 2009 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2009. Online. (ABSTRACT of Poster presented at The Society for Neuroscience annual meeting in Chicago, IL)
Vunck, S.A., Wiebelhaus, J.M., Martorell, E.A., J. Arnt, Porter, J.H. (2009) Adrenergic mechanisms in the discriminative stimulus properties of clozapince and N-Methyl-D-Aspartate (NMDA) in C57BL/6 mice. Program No. 443.27. 2009 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2009. Online. (ABSTRACT of Poster presented at The Society for Neuroscience annual meeting in Chicago, IL.)
Wood, E, Prus, AJ, Porter, JH (2009) Comparison of quantal and graded responding measures of discriminative stimulus control in a two-choice low dose clozapine drug discrimination model. Poster Presented at the 13th Biennial European Behavioral Pharmacology Society meeting in Rome, Italy. (Abstract Published in Behavioural Pharmacology, Vol. 20, Special Issue 1, Sept. 2009, page S103)
Wiebelhaus, JM, Vunck, SA, Porter, JH (2009) A comparison of the discriminative stimulus properties of the metabolite N-desmethylclozapine with clozapine in C57BL/6 mice. Poster Presented at the 13th Biennial European Behavioral Pharmacology Society meeting in Rome, Italy. (Abstract Published in Behavioural Pharmacology, Vol. 20, Special Issue 1, Sept. 2009, page S104)
Vunck, SA, Wiebelhaus, JM, Arnt, J, Porter, JH (2009) Clozapine and N-Methyl-D-Aspartate (NMDA) have positive modulatory actions on their respective discriminative stimulus properties in C57BL/6 mice. Poster Presented at the 13th Biennial European Behavioral Pharmacology Society meeting in Rome, Italy. (Abstract Published in Behavioural Pharmacology, Vol. 20, Special Issue 1, Sept. 2009, page S104)
Wiebelhaus, JM, Vunck, SA, Porter JH (2008) Establishing N-desmethylclozapine (ACP-104), the major metabolite of the atypical antipsychotic drug clozapine, as a discriminative stimulus in C57BL/6 mice. Program No. 657.20. 2008 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2008. Online.
Vunck, SA, Wiebelhaus, JM, Arnt, J, Porter, JH (2008) Comparison of the discriminative stimulus properties of the atypical antipsychotic clozapine and the glutamate agonist N-methyl D-aspartate in a two-lever drug discrimination procedure in C57BL/6 mice, Program No. 657.21. 2008 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2008. Online.
Wood, E, Vunck, SA, Wiebelhaus, JM, Walentiny, DM, Porter, JH (2008) A comparison of the discriminative stimulus properties of the mGluR 2/3 agonist, LY379268 to the atypical antipsychotics clozapine and ziprasidone. Program No. 657.22. 2008 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2008. Online.
Porter, JH, Wood, JT, Pehrson, AL, Tollefson, GD, Bymaster, FP, Cowley, MA (2008) Assessing the combination of fluoxetine plus naltrexone in an animal model of obsessive-compulsive disorder (schedule-induced polydipsia). Program No. 762.25. 2008 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2008. Online.
Walentiny, DM, Philibin, SD, Vunck, SA, Porter, JH (2007) Clozapine drug discrimination in DBA/2 mice. Poster Presented at the 12th Biennial European Behavioral Pharmacology Society meeting in Tubingen, Germany. (Abstract Published in Behavioural Pharmacology, Vol. 18, Supplement 1, Sept. 2007, page S70)
Wood, E, Pehrson, AL, Wood, JT, Prus, AJ, Meltzer HY, Porter, JH (2007) The discriminative stimulus properties of the atypical antipsychotic ziprasidone in rats. Poster Presented at the 12th Biennial European Behavioral Pharmacology Society meeting in Tubingen, Germany. (Abstract Published in Behavioural Pharmacology, Vol. 18, Supplement 1, Sept. 2007, page S70)
Pehrson, AL, Walentiny, DM, Wood, JT, Vunck, SA,Porter, JH (2007) Early postnatal antagonism of glutamatergic NMDA receptors impairs reference and working memory performance but has no effect on locomotor activity in male C57BL/6 mice. Poster Presented at the 12th Biennial European Behavioral Pharmacology Society meeting in Tubingen, Germany. (Abstract published in Behavioural Pharmacology, Vol. 18, Supplement 1, Sept. 2007, page S11)
Vunck, SA, Pehrson, AL, Philibin, SD, Wood, JT, Porter, JH (2007) A comparison of the atypical antipsychotic clozapine with its metabolite N-desmethylclozapine in a two-lever drug discrimination task in Sprague-Dawley rats. Poster Presented at the 12th Biennial European Behavioral Pharmacology Society meeting in Tubingen, Germany. (Abstract Published in Behavioural Pharmacology, Vol. 18, Supplement 1, Sept. 2007, page S70)
Walentiny, DM, Philibin, SD, Vunck, SA, Porter, JH (2007) A comparison of C57BL/6 and DBA/2 mice in a two-lever drug discrimination with the atypical antipsychotic clozapine. Poster presented at The Society for Neuroscience annual meeting in San Diego, CA. (Program No. 711.12. 2007 Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience, 2007. CD-ROM)
Wood, JT, Pehrson, AL, Philibin, SD, Porter, JH (2007) The role of M1 muscarinic receptors in the discriminative stimulus properties of N-desmethylclozapine, the active metabolite of the atypical antipsychotic clozapine. Poster presented at The Society for Neuroscience annual meeting in San Diego, CA. (Program No. 711.16. 2007 Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience, 2007. CD-ROM)
Wood, E, Holton, IS, Pehrson, AL, Prus, AJ, Porter, JH (2007) A comparison of the discriminative stimulus properties of the atypical antipsychotic drugs ziprasidone and clozapine in rats. Poster presented at The Society for Neuroscience annual meeting in San Diego, CA. (Program No. 711.1. 2007 Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience, 2007. CD-ROM)
Pehrson, AL, Walentiny, DM, Wood, JT, Vunck, SA, Porter, JH (2007) Differential effects of early postnatal NMDA antagonism in male and female C57BL/6 mice. Poster presented at The Society for Neuroscience annual meeting in San Diego, CA. (Program No. 498.20. 2007 Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience, 2007. CD-ROM)
Tollefson, GD, Bymaster, FP, Cowley, MA, Wood, JT, Pehrson, AL, Porter, JH (2007) The Combination of Fluoxetine/Naltrexone Exhibits a Synergistic Reduction in Schedule-induced Polydipsia – a Model of Obsessive-Compulsive Disorder. Poster presented at the American College of Neuropsychopharmacology in Miami, FL, December 2007
Porter, JH, Philibin, SD, Walentiny, DM (2006). The clozapine metabolite N-desmethylclozapine potentiates the discriminative stimulus cue of clozapine in C57BL/6 mice. Program No. 768.24. 2006 Abstract Viewer/Itinerary Planner. Atlanta, GA: Society for Neuroscience
Pehrson, AL, Porter, JH (2006). Subchronic phencyclidine (PCP) administration reduces escape latencies in a working memory task in the Morris water maze in C57BL/6 mice: an in-depth analysis. Program No. 753.20. 2006 Abstract Viewer/Itinerary Planner. Atlanta, GA: Society for Neuroscience
Philibin, SD, Walentiny, DM, Prus, AJ, Meltzer, HY, Porter, JH (2006). Clozapine drug discrimination in C57BL/6 mice detects antipsychotic agents based on serotonergic or adrenergic antagonist actions. Program No. 768.22. 2006 Abstract Viewer/Itinerary Planner. Atlanta, GA: Society for Neuroscience
Wood, E, Pehrson, AL, Wood, JT, Prus, AJ, Meltzer, HY, Porter, JH (2006). Two-lever drug discrimination with the atypical antipsychotic ziprasidone differentiates atypical from typical antipsychotic drugs in rats. Program No. 768.23. 2006 Abstract Viewer/Itinerary Planner. Atlanta, GA: Society for Neuroscience
Porter, JH, Stephens CL, Cooper, RN, Prus, AJ, Pehrson, AL, Porter, NP, Glowa, JR (2005). The effects of the SSRI fluoxetine on schedule - induced polydipsia in guinea pigs and rats. Program No. 559.12. 2005 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience
Pehrson, AL, Wood, E, Prus, AJ, Philibin, SD, Porter, JH (2005). Drug discrimination with the atypical antipsychotic ziprasidone in rats. Program No. 913.16. 2005 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience
Philibin, SD, Pehrson, AL, Prus, AJ, Wood, E, Wise, LE, Porter, JH (2005). Clozapine drug discrimination: a species comparison between rats and mice. Program No. 913.17. 2005 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience
Prus AJ, Philibin SD, Pehrson AL, Porter JH (2005) The discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg/kg clozapine vs. 5.0 mg/kg clozapine vs. vehicle in a three-choice drug discrimination task. Behavioural Pharmacology –Supplement 1 (September) 16:S49 (Presented at the 11th biennial European Behavioural Pharmacology Society meeting, Sept. 9 - 12, Barcelona, Spain)
Philibin SD, Prus AJ, Pehrson AL, Wood E, Meltzer HY, Porter JH (2005) The discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL/6 mice. Behavioural Pharmacology –Supplement 1 (September) 16:S49 (Presented at the 11th biennial European Behavioural Pharmacology Society meeting, Sept. 9 - 12, Barcelona, Spain)
Porter JH, Cooper RN, Prus AJ, Stephens CL, Pehrson AL, Porter NP, Glowa JR (2005) The alpha2 antagonist yohimbine accelerates the effects of the SSRI fluoxetine on schedule-induce polydipsia. Behavioural Pharmacology –Supplement 1 (September) 16:S43 (Presented at the biennial European Behavioural Pharmacology Society meeting, Sept. 9 - 12, Barcelona, Spain)
PRESENTATION at the Society for the Stimulus Properties of Drugs, a Satellite Meeting of the 11th Biennial European Behavioural Pharmacology Society meeting, Barcelona, Spain, September 9, 2005 - Title: “Discriminative Stimulus Properties of Typical and Atypical Antipsychotics”
Pehrson, AL, Wise, LE, Philibin, SD, Prus, AJ, Rhodes, MM, Porter, JH (2004) The effects of subchronic administration of phencyclidine (PCP) in C57BL/6 mice on spatial learning in the Morris water maze. Program No. 85.4. 2004 Abstract Viewer/Itinerary Planner. Washington, D.C: Society for Neuroscience
Wise, LE, Pehrson, AL, Porter, JH (2004) The effects of repeated ketamine administration of reversal, extinction, and working memory tasks in the Morris water maze: A putative preclinical model of cognitive dysfunction in schizophrenia. Program No. 85.6. 2004 Abstract Viewer/Itinerary Planner. Washington, D.C: Society for Neuroscience
Philibin, S.D., Prus, A.J., Pehrson, A.L., and Porter, JH (2004) Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL/6 mice. Program No. 1030.10. 2004 Abstract Viewer/Itinerary Planner. Washington, D.C: Society for Neuroscience
Prus, AJ, Philibin, SD, Pehrson, AL, Cooper, RN, Porter, JH (2004) Discriminative stimulus properties of 1.25 mg/kg and 5.0 mg/kg clozapine in a three-choice drug discrimination task. Program No. 1030.17. 2004 Abstract Viewer/Itinerary Planner. Washington, D.C: Society for Neuroscience
Wise, LE, Wade, KLS, Philibin, SD, Barlow, AI, Wilson, MS, Hamm, RJ, Porter, JH (2003) A comparison of olanzapine to risperidone and haloperidol on spatial learning in the Morris Water Maze in rats with an acute dosing regimen. Program No. 625.15. 2003 Abstract Viewer/Itinerary Planner. Washington, D.C: Society for Neuroscience
Porter, JH, Philibin, SD, Barlow, AI, Wade, KLS, Wilson, MS, Pehrson, AL, Wise, LE, Hamm, RJ, (2003) A comparison of olanzapine to risperidone and haloperidol on spatial learning in the Morris Water Maze in rats with a subchronic dosing regimen. Program No. 625.14. 2003 Abstract Viewer/Itinerary Planner. Washington, D.C: Society for Neuroscience
Philibin, SD, Pehrson AL, Prus, AJ, Porter, JH (2003). Two-lever drug discrimination with the atypical antipsychotic clozapine in C57BL/6 mice. Program No. 858.8. 2003 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience
Prus AJ, Wise LE, Pehrson AL, Thompson AD, Stephens CL, Philibin SD, Porter JH (2003) Discriminative stimulus properties of 1.25 mg/kg clozapine: generalization testing with muscarinic antagonists and other receptor – selective ligands. Program No. 858.14. 2003 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience
Pehrson AL, Wise LE, Philibin SD, Prus AJ, Rhodes MM, Porter JH (2003) The effects of acute and subchronic administration of phencyclidine (PCP) on performance of C57BL/6 mice in the Morris Water Maze. Program No. 754.13 2003 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience
Prus, AJ, Philibin, SD, Varvel, SA, Vann, RE, Porter, JH (2003). Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure. Behavioural Pharmacology – Supplemental issue (Poster presented at the 2003 meeting of the European Behavioural Pharmacology Society).
Philibin, SD, Wise, LE, Pehrson, AL, Silver, KL, Vann, RE, Porter, JH (2002) Effects of subchronic ketamine on 8-arm radial maze performance in rats. Program No. 494.9. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. Online
Wise, LE, Vann, RE, Pehrson, AL, Philibin, SD, Porter JH (2002) Reversal learning in the 8-arm radial maze in rats is impaired by subchronic administration of the noncompetitive NMDA antagonist ketamine. Program No. 494.7. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. Online
Pehrson, AL, Wise, LE, Philibin, SD, Silver, KL, Porter, JH (2002) The effects of subchronic PCP on 8-arm radial maze performance in mice. Program No. 494.8. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. Online
Wise, LE, Vann, RE, Philibin, SD, Carter, SM, Varvel, SB, Pehrson, AL, Silver, KL, and Porter, JH (2001) Discriminative stimulus properties of the atypical antipsychotic clozapine in rats with a low training dose. Society for Neuroscience Abstracts, 27
Philibin, SD, Carter, SM, Vann, RE, Pehrson, AL, Wise, LE, Varvel, SB, Silver, KL, and Porter, JH (2001) Assessment of the paw test procedure in mice: A comparison of the antipsychotic drugs clozapine, olanzapine, haloperidol, and chlorpromazine. Society for Neuroscience Abstracts, 27
From 1971 to 2000 – over 70 published abstracts and 100 presentations at scientific meetings
January 26, 2017